An association study of FOXO3 variant and longevity

Abstract

Human longevity is a polygenic and multifactorial trait. Pathways related to lifespan are complex and involve molecular, cellular, and environmental processes. In this analytical observational study, we evaluated the relationship between environment factors, oxidative stress status, DNA integrity level, and the association of FOXO3 (rs2802292), SOD2 (rs4880), APOE (rs429358 and rs7412), and SIRT1 (rs2273773) polymorphisms with longevity in oldest-old individuals from southeastern Brazil. We found an association between the FOXO3 GG genotype and gender. While lifestyle, anthropometric, and biochemical characteristics showed significant results, DNA damage and oxidative stress were not related to lifespan. We found that long-lived individuals with FOXO3 GT genotype had low levels of triglycerides. This study is the first to demonstrate that FOXO3 could be a candidate gene for longevity in the Brazilian population. These results are important in terms of provisions of health care for age-related diseases and lifespan, and provide insight for further research on epigenetic, gene regulation, and expression in oldest-old individuals.

Keywords:
Lifespan; SNPs; environmental factors; oxidative stress; genomic damage

Introduction

Life expectancy in the world has more than doubled in the last two centuries. People aged 85 years or more, often designated the “oldest-old”, are the fastest-growing age group. Longevity is a multifactorial condition, affected by environmental and genetic factors, as well as by oxidative and genomic damage. Several hypotheses have been postulated to explain aging and lifespan, which have attracted widespread scientific and public interest (Brooks-Wilson, 2013; Simm and Klotz, 2015). The reactive oxygen species (ROS) theory of aging is related to oxidative stress and macromolecule damage. Twin-based research has shown that the genetic contribution is approximately 25% and becomes more profound after the age of 85 (Perls et al., 2000). Single nucleotide polymorphisms (SNPs) are commonly used in human longevity studies to investigate common variants associated with lifespan.

The Forkhead box O3 (FOXO3) gene mediates metabolic and oxidative stress, and participates in the insulin/insulin-like growth factor-1 signaling (IIS) pathway. Because of this, rs2802292 FOXO3 has been associated with lifespan (Soerensen et al., 2015). Also involved with longevity is the SOD2 (Superoxide Dismutase 2) gene, which encodes a manganese-dependent superoxide dismutase enzyme (Mn-SOD) and is implicated with oxidative stress. Among the SNPs in SOD2 related to longevity, rs4880 is the most studied (Gentschew et al., 2013). Another gene largely studied in reference to longevity and diseases that affect older people has been the Apolipoprotein E gene (APOE). Two SNPs, rs429358 and rs7412, encode a protein of relevance in the process of lipid metabolism ( Zhong et al., 2016). Sirtuin 1, or SIRT1, (Silent Information Regulator Type 1) is a NAD⁺-dependent deacetylase that belongs to a family of SIR proteins. SIRT1 rs2273773 has been shown to be involved in DNA repair, resistance to oxidative stress, and lifespan (Howitz et al., 2003).

Studies on the association between longevity and genetic, oxidative, and genomic damage markers have significant clinical importance (Fragoso et al., 2015). However, these works have often yielded conflicting results and not all genetic variants have been replicated. Therefore, the main objective of this work was to study the association of FOXO3 (rs2802292), SOD2 (rs4880), APOE (rs429358 and rs7412), and SIRT1 (rs2273773) polymorphisms with longevity, oxidative stress status, and DNA integrity level in oldest-old individuals from southeastern Brazil.

Materials and Methods

Subjects

This is an observational and analytical study of 452 unrelated individuals. The sample of long-lived individuals (LLI) included 220 participants with age ≥85 years. The control group had 232 elders with ages between 70-75 years, which is close to the 73.5-year-average lifespan of the Brazilian population (Instituto Brasileiro de Geografia e Estatística, 2010). The chosen age range of controls is in accordance with studies, which claim that elderly people with age close to the lifespan of a certain population are more prone to genetic factors then to environmental factors (Willcox et al., 2008; Anselmi et al., 2009; Flachsbart et al., 2009). Moreover, there is no data about mortality control in Brazil. Likewise, recent predictions by the Instituto Brasileiro de Geografia e Estatística (2013), in the Complete Mortality Table for Brazil, state that the Brazilian elderly population presented life expectancy from 84.7 years to the exact age of 70 years and from 86.7 years to the exact age of 75. Therefore, it is expected that a small portion of the controls admitted in our study will reach the age established for the LLI group, since they presented a mean survival time of 13.2 years (average between 70-84.7 and 75-86.7 years). In each group, sex and age were matched.

All the selected participants were from the metropolitan region of Espírito Santo, Grande Vitória, in Southeast Brazil. A geriatrician assisted all participants for 20 years in the Geriatric Unit of the Santa Casa de Misericórdia de Vitória Hospital resting home, (Abrigo à Velhice Desamparada Alta Loureiro Machado, ES, Brazil). This study was approved by the Committee of Human Research of the Universidade Federal do Espírito Santo, Health Sciences Center, Brazil, and performed in accordance with The Code of Ethics of the World Medical Association. To participate in the study, elders or their relatives gave written informed consent. Each individual answered a questionnaire adapted from the International Commission for Protection against Environmental Mutagens and Carcinogens (Carrano and Natarajan, 1988), the Program Gênesis-Gravataí (Flores et al., 2013), and the Survey on Quality of Life Short Form 36 - SF36, adapted to the Brazilian population (Ware and Sherbourne, 1992). Questions were about demographic and socioeconomic characteristics, such as age, sex, ethnicity, education and income, smoking and alcohol consumption, physical activity, diet, and medical issues like vaccinations, medication, chronic diseases, mental health, and functional ability. A face-to-face interview with the participants was done by trained researchers. Medication and the presence of disease were confirmed through the patients’ records.

Blood sampling

The blood samples were collected in 2014 and 2015. Eight milliliters of peripheral blood was collected into a 5% ethylene diamine tetraacetic acid (EDTA) tube (Vacuette, Greiner Labortechnik, Germany). For genotyping, samples were stored at 4 °C prior to analyses. For the oxidative stress and genomic damage analyses, 4 mL of blood were reserved. Genomic DNA was extracted according to previous methodology (Miller et al., 1988). Concentration and purity of genomic DNA were measured using a NanoDrop 2000 Spectrophotometer (Thermo Fisher Scientific, Delaware, USA).

Anthropometric, physical and biochemical data

Measurements of body mass index (BMI) and waist-hip ratio (W/H) were taken from the subjects. Height and weight were assessed with a stadiometer and a scale (Filizola, São Paulo, Brazil), and the hip and waist measurements were taken with a non-extendable anthropometric tape (Sanny, São Paulo, Brazil). Subjects were categorized into BMI groups according to Panamerican Health Organization (Organizacão Pan-Americana da Saúde, 2003) criteria. For the waist-hip ratio classification, cut-off point values were adopted: <1.0 for men and <0.85 for women (World Health Organization, 2000). Biochemical and physical data were defined using the specific criteria of Xavier et al. (2013) and Oliveira et al. (2015) and assessed through patients’ records.

Oxidative stress analysis and comet assay

Participants selected for malondialdehyde (MDA) analysis, an oxidative stress parameter, and alkaline comet assay had to be non-smokers, not be taking antioxidant supplements, not consume alcohol, not have recently undergone x-ray scans, and not have recently undergone surgeries. A total of 100 participants, 50 LLI and 50 controls, were evaluated for MDA levels. Plasma samples of subjects were analyzed for MDA levels by high performance liquid chromatography with diode-array detection (HPLC-DAD) (Antunes et al., 2008) and run in duplicate. Average values were reported as μmol/L of plasma.

To investigate genotoxic damage to peripheral blood cells, 15 LLI and 15 controls were evaluated using an alkaline comet assay, as previously described (Singh et al., 1988; Tice et al., 2000). DNA damage was determined by analysis of 100 randomly selected cells from each individual, and measurement of tail size, scored visually, was divided into four categories, ranging from no tail (no damage) to maximally long tails (maximum damage).

Genotyping

FOXO3 (rs2802292:G>T, RefSeqNM_001455.3), SOD2 (rs4880:T>C, RefSeqNG_008729.1), SIRT1 (rs2273773:T>C, RefSeqNM_001142498.1), and APOE (rs429358:T>C, RefSeqNG_007084.2 and rs7412:C>T, RefSeqNG_007084.2) SNPs were genotyped for 449 individuals by real-time polymerase chain reaction (qPCR). Thirty ηg/μL of genomic DNA were used for qPCR according to the manufacturer’s instructions (TaqMan SNP Genotyping Assay - Applied Biosystems, Carlsbad, California, USA), and the reactions were performed on a Rotor-Gene Q (Qiagen, Hilden, Germany). Genotypes were analyzed using the Rotor Gene Q Series Software v.2.1 (Qiagen). To validate the standard genotypes found in each SNP, Sanger sequencing was performed on an ABI PRISM 3130XL Genetic Analyzer/HITACHI (Applied Biosystems). The sequencing analysis was performed using the BioEdit software v.7.2.5 for windows (Ibis Biosciences, Carlsbad, California, USA).

Statistical analysis

Statistical analysis of the data was performed using SPSS software v 23.0 for Windows (IBM corporation, Armonk, New York, USA) and p<0.05 values were considered significant. To test the association between longevity and the rs2802292 FOXO3, rs4880 SOD2, rs429358 and rs7412 APOE, and rs2273773 SIRT1 polymorphisms, Pearson’s Chi-square or Fisher’s exact tests, with odds ratio (OR) and confidence intervals (CI) of 95%, were carried out. Moreover, the Hardy-Weinberg Equilibrium (HWE) was calculated (p<0.05).

Frequencies of demographic and socioeconomic characteristics were compared for each gender and for both groups (controls and long-lived) using Pearson’s Chi-square or Fisher’s exact tests for categorical variables, and Student’s t-tests for continuous variables. For the comparison of biochemical, physical, anthropometric characteristics, and oxidative stress status between LLI and control groups, Student’s t-test was used for continuous variables. The normality of the data was verified. For genomic damage analysis, the comparison between LLI and controls was performed using a Mann-Whitney test.

To evaluate the distribution of the oxidative damage product, DNA damage, clinical, anthropometric, and biochemical characteristics according to FOXO3 genotypes, within long-lived individuals and controls, we used one-way analysis of variance (ANOVA), followed by Tukey and Pearson’s Chi-square tests for categorical variables. To test the association between FOXO3, SOD2, APOE, and SIRT1 genotypes and the health status of long-lived individuals, Pearson’s Chi-square or Fisher’s exact tests were used. “Healthy” was defined as absence of chronic diseases (cardiovascular disease, diabetes, cancer, neurodegenerative, and respiratory diseases) and good functional ability (Willcox et al., 2008; Ware and Sherbourne, 1992).

Results

Demographic, socioeconomic, anthropometric, biochemical, and physical characteristics of the groups as well as oxidative stress status and genomic damage, are shown in Table 1. The average ages are 72.4 ± 1.7 years for controls and 89.3 ± 4.6 years for LLI. Female participants are predominant in the sample, as well as Caucasian individuals. Most individuals live in their own homes. Among the long-lived individuals, 63.2% were 85–89 years old, 33.6% were nonagenarians, and 3.2% were centenarians.

Table 1
Characteristics of study sample.

Characteristics (n)	LLI			Controls			p **
Gender (452)	Men (64)	Women (156)	p*	Men (75)	Women (157)	p*
Age (452)	88.8 ± 4.1	89.3 ± 4.6	0.467	72.3 ± 1.8	72.4 ± 1.7	0.457	0.000
Ethnicity (449)
Caucasian	38 (17.4%)	93 (42.5%)		48 (20.9%)	100 (43.5%)
Black	9 (4.1%)	26 (11.9%)	0.898	12 (5.2%)	21 (9.1%)	0.755	0.612
Brown	16 (7.3%)	37 (16.9%)		14 (6.1%)	35 (15.2%)
Descent Family - Italy (87)	37 (42.5%)		50 (57.5%)				0.099
Marital status (330)							0.000
Married	42 (25.8%)		85 (50.9%)
Widower	94 (57.6%)		53 (31.7%)
Separated/divorced/never married	27 (16.6%)		29 (17.4%)
Monthly Income ($200.00) (297)	150 (50.5%)		147 (49.5%)
Years of Education (325)							0.015
0 years	15 (9.9%)	51 (31.7%)	0.255	9 (5.5%)	34 (20.7%)
1-4 years	29 (18.0%)	48 (29.8%)		34 (20.7%)	61 (37.2%)	0.325
5-8 years	4 (2.5%)	11 (6.8%)		8 (4.9%)	14 (8.5%)
> 8 years	1 (0.6%)	1 (0.6%)		1 (0.6%)	3 (1.8%)
Home (290)							0.108
Own home	119 (88.1%)			145 (93.5%)
Rented/ Live with other	16 (11.9%)			10 (6.5%)
Biochemical physical and anthropometric data
Diastolic Blood Pressure (mmHg) (299)	77.4 ± 10.4			79.5 ± 11.3			0.675
Systolic Blood Pressure (mmHg) (299)	133.9 ± 20.1			134.9 ± 20.7			0.093
Cholesterol (mg/dl) (257)	181.9 ± 39.9			187.9 ± 43.6			0.256
High-Density Lipoprotein Cholesterol (mg/dl) (246)	48.8 ± 10.6			46.7 ± 12.8			0.177
Low-Density Lipoprotein Cholesterol (mg/dl) (242)	110.1 ± 33.6			111.9 ± 38.7			0.701
Triglycerides (mg/dl) (249)	120.9 ± 73.6			152.0 ± 111.3			0.009
Glucose (mg/dl) (279)	106.9 ± 28.3			118.1 ± 47.4			0.017
Waist:hip ratio (265)	0.9 ± 0.1			0.9 ± 0.1			0.984
BMI (251)							0.003
< 23 kg/m2 (Underweight)	36 (31.3%)			22 (16.2%)
23 |- 28 kg/m2 (Normal weight)	58 (50.4%)			64 (47.1%)
28 |-30 kg/m2(Overweight)	7 (6.1%)			18 (13.2%)
> = 30 kg/m2 (Obesity)	14 (12.2%)			32 (23.5%)
Eat Vegetables (5 times/day) (309)							0.174
Yes	122 (39.5%)			128 (41.4%)
No	23 (7.4%)			36 (11.7%)
Eat Fruits (5 times/day) (309)							0.052
Yes	124 (40.1%)			126 (40.8%)
No	21 (6.8%)			38 (12.3%)
Alcohol consumption (326)							0.019
Use	6 (3.8%)	4 (2.5%)	0.071	18 (10.7%)	6 (3.6%)	0.000
No use	43 (27.2%)	105 (66.5%)		36 (21.4%)	108 (64.3%)
Smoker Status (328)							0.229
Never smoked	21 (13.3%)	73 (46.2%)	0.008	21 (12.4%)	95 (55.9%)
Former smoked	25 (15.8%)	30 (19.0%)		30 (17.6%)	18 (10.6%)	0.000
Current smoked	4 (2.5%)	5 (3.2%)		5 (2.9%)	1 (0.6%)
Physical activity (283)							0.004
Yes	11 (24.4%)	10 (11.2%)	0.047	17 (38.6%)	28 (26.7%)	0.147
No	34 (75.6%)	79 (88.8%)		27 (61.4%)	77 (73.3%)
Family history (68)							0.006
Cardiovascular Disease	13 (44.8%)		4 (10.5%)
Diabetes	5 (17.2%)		11(28.9%)
Cancer	11 (38.0%)		23 (60.5%)
Malondialdehyde (μmol/L plasma) (100)	1.99 ± 0.66	2.03 ± 0.73	0.879	1.91 ± 0.62	1.77 ± 0.63	0.447	0.137
Genomic damage (a.u.) (30)b	0.044 ± 0.011		0.031 ± 0.007				0.567

The data are presented as mean ± SD or SEM
• ^b
  (standard deviation or standard error of the mean) or number of subjects with percentage in parentheses. Abbreviations: n - number of individuals; LLI - Long-Lived Individuals; a.u. - arbitrary units;
• ^*
  Comparison between gender;
• ^**
  Comparison between Controls and LLI; p-values are uncorrected; the adjusted residue of χ2 test were used for significant data.

A significant difference in marital status was observed for married controls (50.9%) and LLI widowers (57.6%) (p=0.000). Most participants had one to four years of formal education, with a significant difference between groups (p=0.015); the LLI group had a higher number of individuals who lacked formal education. They also showed lower triglycerides (p=0.009), lower glucose (p=0.017), and low BMI (p=0.003). We observed that the LLI had a higher fruit intake per day, although this had a borderline significance (p=0.052). In the sample as a whole, the average BMI was 26.00 ± 4.57 kg/m². According to the W:H ratio, 19.4% of men and 45.4% of women presented risk for metabolic disease (data not shown).

Most individuals did not consume alcohol. We observed a significant difference in alcohol consumption between groups (p=0.019). Men and women in the control sample drank less alcohol (p=0.000).

Concerning smoking, we found a higher proportion of women who never smoked, of men who quit smoking, and of men who currently smoke, both in long-lived (p=0.008) and control (p=0.000) groups.

Most individuals reported they did not exercise. Comparing the groups, there was a difference in the proportion of people who did not exercise (p=0.004). In LLI, the difference in proportion between men and women was slightly significant (p=0.047).

As for medical family history, cancer was more frequently observed in controls (60.5%), whereas heart disease was more frequently observed in LLI (44.8%). The difference in proportion between controls and LLI was significant (p=0.006). In both malondialdehyde and DNA damage analyses, average levels were higher in LLI than in controls, although non-significant.

The genotype and allele frequencies of FOXO3 (rs2802292), SOD2 (rs4880), APOE (rs429358 and rs7412), and SIRT1 (rs2273773) for both genders, LLI, and controls are shown in Table 2. In the LLI group, an association was observed between FOXO3 GG genotype and gender (OR=0.348; 95% CI=0.139-0.873; p=0.02). However, no association was found between this genotype and longevity, considering the stratification of the sample in elderly men (OR=0.414; 95% CI=0.150-1.142; p=0.088) and elderly women (OR=1.137; 95% CI=0.666-1.941; p=0,639) within the two groups. No significant difference was observed for the other SNPs. All LLI and control polymorphisms were found in HWE.

Table 2
Distribution of genotypes and alleles in study groups.

	Groups (n)	LLI (218)					Controls (231)					OR(95% CI)**	p **	p ***
Genes	Genotypes	Men	Women	Total	OR (95% CI)*	p *	Men	Women	Total	OR (95% CI)*	p *
		n (%)	n (%)	n (%)			n (%)	n (%)	n (%)
					0.348					0.955		0.910
FOXO3	GG	6 (2.8)	36 (16.5)	42 (19.3)	(0.139-0.873)	0.020	15 (6.5)	33 (14.3)	48 (20.8)	(0.482-1.894)	0.896	(0.573-1.445)	0.689	0.907
					1.425					0.869		1.073
	GT	38(17.4)	80 (36.7)	118(54.1)	(0.786-2.583)	0.242	37 (16.0)	84 (36.4)	121(52.4)	(0.500-1.511)	0.619	(0.740-1.555)	0.711
					1.284					1.238		0.988
	TT	19 (8.7)	39 (17.9)	58 (26.6)	(0.671-2.458)	0.449	22 (9.5)	40 (17.3)	62 (26.8)	(0.670 - 2.287)	0.496	(0.650-1.501)	0.955
SOD2
					0.841					1.412		0.987
	CC	15 (6.9)	42 (19.3)	57 (26.1)	(0.426-1.659)	0.617	23 (10.0)	38 (16.5)	61 (26.4)	(0.765-2.607)	0.269	(0.648-1.502)	0.950	0.369
					1.070					0.821		1.238
	CT	36(16.5)	86 (39.4)	122(56.0)	(0.592-1.932)	0.823	35 (15.1)	82 (35.5)	117(50.6)	(0.472-1.428)	0.484	(0.854-1.795)	0.259
					1.115					0.895		0.732
	TT	12 (5.5)	27 (12.4)	39 (17.9)	(0.525-2.370)	0.776	16(6.9)	37 (16.0)	53 (22.9)	(0.460-1.740)	0.743	(0.461-1.162)	0.185
APOE
					1.291					0.996		1.088
	∊2∊3	10 (4.7)	16 (7.5)	26 (12.2)	(0.553-3.012)	0.658	8 (3.8)	20 (9.4)	28 (13.2)	(0.412-2.401)	1.000	(0.615-1.927)	0.884	0.973
					1.493					0.904		1.079
	∊3∊3	43(20.1)	72 (33.8)	115(53.9)	(0.837-2.662)	0.191	33 (15.5)	86 (40.4)	119(55.9)	(0.498-1.643)	0.762	(0.736-1.580)	0.770
					0.492					2.542		0.796
	∊2∊4	1 (0.5)	4 (1.9)	5 (2.4)	(0.054-1.889)	0.667	2 (0.9)	2 (0.9)	4 (1.8)	(0.350-18.468)	0.324	(0.211-3.006)	1.000
					0.547					1.105		0.885
	∊3∊4	14 (6.6)	44 (20.7)	58 (27.3)	(0.276-1.084)	0.102	16 (7.5)	37 (17.4)	53 (24.9)	(0.560-2.182)	0.861	(0.574-1.365)	0.659
					1.000					0.702		1.000
	∊4∊4	3(1.4)	6 (2.8)	9 (4.2)	(0.243-4.121)	1.000	2 (0.9)	7 (3.3)	9 (4.2)	(0.142-3.479)	1.000	(0.389-2.570)	1.000
SIRT1
					2.508					2.137		2.140
	CC	2 (0.9)	2 (0.9)	4 (1.8)	(0.346-18.208)	0.347	1 (0.4)	1 (0.4)	2 (0.8)	(0.132-34.643)	0.584	(0.388-11.804)	0.438	0.660
					0.936					0.661		0.945
	CT	10 (4.6)	26 (11.9)	36 (16.5)	(0.422-2.076)	0.871	10 (4.3)	30 (13.0)	40 (17.3)	(0.304-1.437)	0.294	(0.576-1.548)	0.821
					0.937					1.409		0.989
	TT	51(23.4)	127(58.3)	178(81.7)	(0.442-1.984)	0.865	63 (27.3)	126(54.5)	189(81.8)	(0.665-2.987)	0.370	(0.613-1.596)	0.964
		LLI	Controls
	Allele	n	%	n	%	p **	OR (95%CI)
							0.975
FOXO3	G	202	46.3	217	47.0	0.848	(0.750-1.267)
							1.026
	T	234	53.7	245	53.0	0.472	(0.789-1.334)
SOD2	C	236	54.1	239	51.7		1.101
							(0.847-1.431)
	T	200	45.9	223	48.3		0.908
							(0.699-1.181)
APOE	∊2	31	7.3	32	7.5	0.867	0.904
							(0.542-1.509)
	∊3	314	73.7	319	74.9		0.768
							(0.576-1.024)
	∊4	81	19.0	75	17.6		1.018
							(0.721-1.438)
SIRT1	C	44	10.1	44	9.5	0.775	1.066
							(0.687-1.656)
							0.938
	T	392	89.9	418	90.5		(0.604-1.456)

Abbreviations: n= number of individuals; LLI = Long-Lived Individuals; OR = Odds Ratio; CI = Confidence Interval;
• ^*
  Comparison between gender;
• ^**
  Comparison between CT and LLI;
• ^***
  p-values are uncorrected; For APOE, n= 213 (LLI) and n= 213 (Controls). FOXO3 (rs2802292:G>T. RefSeqNM_001455.3), SOD2 (rs4880:T>C. RefSeqNG_008729.1), SIRT1 (rs2273773:T>C. RefSeqNM_001142498.1) and APOE (rs429358:T>C. RefSeqNG_007084.2 and rs7412:C>T. RefSeqNG_007084.2).

Comparing the distribution of biochemical variables with the FOXO3 genotypes, there was significant difference between the average triglyceride levels among LLI (p=0.036): individuals with the TG genotype showed low levels of triglycerides, while individuals with the TT genotype showed high levels of triglycerides. For other variables (clinical variables, and oxidative and genomic damage) no significant difference was found (Table 3). The distribution of FOXO3, SOD2, APOE, and SIRT1 genotypes between healthy and frail LLI was also assessed, and data are shown in Table 4, though no significant difference was observed. We did not find an association of protective genotypes between health status and longevity.

Table 3
Biochemical, anthropometric, clinical variables, oxidative and genomic damages according FOXO3 genotypes.

	FOXO3 SNP Genotypes (rs2802292)
Variables (n)/Groups	GG	GT	TT	p *
Triglycerides (mg/dl) (249)
LLI	108.2 ± 34.0	109.8 ± 63.6a	147.6 ± 96.9a	0.036
Controls	150.1 ± 131.6	148.6 ± 83.7	163.1 ± 140.2	0.818
Glucose (mg/dl) (279)
LLI	109.2 ± 37.5	106.1 ± 26.4	107.1 ± 25.1	0.896
Controls	122.8 ± 50.6	119.6 ± 48.9	106.8 ± 25.7	0.226
Body Mass Index (251)
LLI	25.1 ± 3.7	24.3 ± 4.7	26.7 ± 4.7	0.070
Controls	26.7 ± 4.4	26.8 ± 4.6	27.4 ± 4.8	0.760
Heart disease (236)
LLI	19 (45.2%)	65 (55.1%)	30 (51.7%)	0.545**
Controls	26 (54.2%)	61 (50.4%)	35 (56.5%)	0.725**
Diabetes (108)
LLI	6 (14.3%)	24 (20.3%)	10 (17.2%)	0.663**
Controls	14 (29.2%)	36 (29.8%)	18 (29.0%)	0.994**
Malondialdehyde (μmol/L plasma) (100)
LLI	1.68 ± 0.23	1.91 ± 0.66	2.28 ± 0.74	0.116
Controls	1.88 ± 0.75	1.81 ± 0.55	1.58 ± 0.24	0.393
Genomic damage (a.u.) (30)b
LLI	0.015 ± 0.009	0.065 ± 0.017	0.027 ± 0.012	0.108
Controls	0.045 ± 0.025	0.027 ± 0.008	0.032 ± 0.014	0.731

The data are presented as mean ± SD or SEM
• ^b
  (standard deviation or standard error of the mean) or number of subjects with percentage in parentheses. Abbreviations: n - number of individuals; LLI - Long-Lived Individuals; a.u. - arbitrary units;
• ^*
  Comparison between mean values of parameters for genotypes within LLI and controls;
• ^**
  Odds Ratio was not calculated because p > 0.05;
• ^a
  p < 0.05 (Tukey test); For heart disease and diabetes, values refer to that morbidity carrier.FOXO3 (rs2802292:G > T. RefSeqNM_001455.3).

Table 4
Distribution of FOXO3, SOD2, APOE and SIRT1 genotypes between healthy and frailty status of the long-lived individuals.

Gene	Genotypes/Groups (n)	Healthy LLI (83)	Frail LLI (135)	p *	OR (95% CI)**	p **
		n (%)	n (%)
FOXO3	GG	19 (22.9)	23 (17)		1.446 (0.732 - 2.856)	0.287
	GT	43 (51.8)	75 (55.6)	0.567	0.860 (0.497 - 1.488)	0.590
	TT	21(25.3)	37 (27.4)		0.897 (0.482 - 1.673)	0.733
SOD2	CC	25 (30.1)	32 (23.7)		1.387 (0.751-2.565)	0.295
	CT	41(49.4)	81 (60.0)	0.342	0.651 (0.375-1.129)	0.125
	TT	17 (20.5)	22 (16.3)		1.323 (0.656-2.670)	0.433
APOE	∊2∊3	11 (13.6)	17 (12.9)		1.063 (0.471-2.400)	0.883
	∊3∊3	39 (48.1)	80 (60.6)		0.640 (0.345-1.055)	0.075
	∊2∊4	1 (1.2)	3 (2.3)	0.313	0.538 (0.055-5.257)	1.000
	∊3∊4	25 (30.9)	28 (21.2)		1.658 (0.883-3.112)	0.114
	∊4∊4	5 (6.2)	4 (3.0)		2.105 (0.548-8.080)	0.306
SIRT1	CC	3 (3.6)	1 (0.7)		5.025 (0.514-49.160)	0.156
	CT	12 (14.5)	24 (17.8)	0.292	0.782 (0.367-1.662)	0.577
	TT	68 (81.9)	110 (81.5)		1.030 (0.507-2.092)	1.000

Abbreviations: n - number of individuals; LLI - Long-Lived Individuals; OR - Odds Ratio; CI - Confidence Interval;
• ^*
  Comparison between genotypes of frailty and healthy status;
• ^**
  p-value for Odds Ratio; For APOE, n= 81 (Healthy LLI) and n= 132 (Frailty LLI). FOXO3 (rs2802292:G > T. RefSeqNM_001455.3), SOD2 (rs4880:T > C. RefSeqNG_008729.1), SIRT1 (rs2273773:T > C. RefSeqNM_001142498.1) APOE (rs429358:T > C. RefSeqNG_007084.2 and rs7412:C > T. RefSeqNG_007084.2).

Discussion

The present study aimed to evaluate the association of FOXO3 (rs2802292), SOD2 (rs4880), APOE (rs429358 and rs7412), and SIRT1 (rs2273773) polymorphisms with longevity and the relationship between genomic damage and oxidative stress status in elderly people of southeastern Brazil. A polymorphism of FOXO3 had an association with gender, and anthropometric and biochemical characteristics showed significant results. No relationship was found between longevity and DNA damage status or oxidative stress.

Environmental factors may play a role in age-related diseases and longevity, but the relative importance of these factors remains unclear. Previous studies have demonstrated that lifestyle, diet, socioeconomic, biochemical, and anthropometric characteristics affect the development of age-related diseases as well as the health and lifespan of the general population (Praticò, 2002; Britton et al., 2008). Dutta et al. (2011) found no relationship between years of education and lifespan. In our study, we noted that 86.8% of controls and LLI had up to four years of education. We believe that this is because in the 1930s, these individuals had less access to education in Brazil. In addition, the typical monthly income of an elderly in our sample was $200.00, which could also explain the lower education levels. A majority of the LLI are widowed and of the controls, married. However, the Dutta et al. (2011) study, that accompanied elderly from 65 to 85 years, showed that on average, marital status did not influence the survival of participants.

Analysis of other biological factors in our study showed low levels of triglycerides and glucose, low BMI, low alcohol consumption (93.7%), and a tendency, in the LLI group, to eat more fruits per day. Dutta et al. (2011) had also shown that participants with a BMI of 30.0 kg/m² were less likely to achieve longevity. In a longitudinal study, Hodge et al. (2014) noted that longevity was correlated with both fruit consumption and moderate alcohol consumption. In the Multinational MEDIS Study, the oldest-old had lower BMI levels and a prevalence of dyslipidemia, but no difference between controls and oldest-old relative to education status and marital status (Tyrovolas et al., 2016). We believe these parameters are related with successful aging in our study.

DNA damage and products of oxidative stress have also been studied in relation to longevity. No difference in the levels of these two biomarkers was observed in our sample. Lower levels of malondialdehyde may not have been found because most of the studied individuals, in both control and LLI groups, had diseases related to aging that could promote oxidative imbalance. As for DNA integrity, studies show that ≥85-year-old individuals have levels of genomic lesions either higher than or similar to younger elders (Franzke et al., 2015). However, our results characterize the frailty of aging per se, as discussed in Taufer et al. (2005). Moreover, we cannot rule out other defense pathways against oxygen reactive species and/or biomarkers that were not studied in the present work and which may affect longevity (Praticò, 2002; Saeed et al., 2005). The hypothesis of oxidative stress resistance states that the increased genomic damage with age is accompanied by efficient antioxidant and repair mechanisms for successful aging (Franzke et al., 2015).

In relation to candidate genes for longevity, Genome Wide Association Studies (GWAS) show that APOE and FOXO3 are associated to human lifespan (Christensen et al., 2006; Broer et al., 2015). SOD2 and SIRT1 are also great predisposition genes, having been the focus of many studies (Taufer et al., 2005; Flachsbart et al., 2006; Soerensen et al., 2009; Gentschew et al., 2013; Han et al., 2015).

FOXO3 is localized in Ch6q21 and belongs to a subfamily of transcription factors that target longevity regulators, implicated in the insulin and insulin-like growth factor signaling pathways (Martins et al., 2016). The FOXO3 protein is involved in diverse cellular and physiological processes, including cell proliferation, apoptosis, cellular responses to oxidative stress, cancer, cell cycle regulation, metabolism, and longevity (Tzivion et al., 2011). The rs2802292 in FOXO3 is a G > T change. A study of the Danish population investigated 15 SNPs in the FOXO3 gene and involved 1088 participants (Soerensen et al., 2015). This research showed a positive association between FOXO3 rs2802292 and 4 other SNPs of this gene with phenotypes shown to predict survival in a combined sample of male and female oldest-old individuals. No association between FOXO3 and type 2 diabetes was found in an elderly Indian population study, which included a sample of 994 type 2 diabetic individuals and 984 normoglycemic controls (Nair et al., 2012). In our sample, we found a significant gender-related difference for GG genotype in the LLI group, although lifespan was not associated with the FOXO3 GG genotype, in neither men nor women.

Unlike our study, Willcox et al. (2008) and Anselmi et al. (2009) found that the FOXO3 GG genotype was associated with longevity in long-lived Japanese and Italian men, respectively. Willcox et al. (2008) also observed that the G allele and GG genotype frequencies tended to be increased in long-lived vs control men. A possible reason for the FOXO3 SNP results found in our study is the small sample size (in gender-specific effect), which may decrease the statistical power to detect associations. FOXO3 may play a role in determining longevity, probably by enabling those who have the protective genotype to be shielded in some way from oxidative stress, cell death, and glucose metabolism (Soerensen et al., 2015). Moreover, in our work the oldest individuals carrying the G allele (in the GT genotype) of FOXO3 had lower levels of triglycerides compared to individuals who were homozygous for the T allele. These results corroborated with Willcox et al.‘s (2008) work, which found that lower levels of triglyceride may be a phenotype related to healthy aging, and that individuals with at least one G allele have a higher protection factor for longevity compared to individuals homozygous for the T allele. Lower triglyceride values (≤150 mg/dL), similar to other variables, are inversely correlated with the increase of visceral adipose tissue and thus with a lower risk for metabolite disease development (Xavier et al., 2013) that may culminate in an unsuccessful aging process. However, we did not identify an association between the G allele of FOXO3 and lifespan in our work.

The SOD2 protein (Mn-SOD) is involved in oxidative stress regulation, which is a pathway that leads to longevity. It is a great defense against ROS in the mitochondria and acts at the matrix, converting superoxide radicals into hydrogen peroxide (da Cruz, 2015). The rs4880 in SOD2 (Ch6q25.3) is a T > C that replaces valine for alanine, which may disturb the SOD2 protein activity and unbalance the oxidant-antioxidant equilibrium in the mitochondria (Shimoda-Matsubayashi et al., 1996). Although this rs4880 SNP is the most studied in SOD2 (Gentschew et al., 2013), results from different studies are inconsistent. One of these works tested the association of the rs4880 SNP with longevity in a sample of 1650 long-lived individuals from Denmark, and observed that individuals with the C allele had decreased mortality (p=0.002) (Soerensen et al., 2009). A study conducted in the south of Brazil tested for age-related mortality with 489 volunteers divided into three groups (newborns, 21-79-year-old adults, and 80-105-year-old elders), but no association was found (Taufer et al., 2005). Gentschew et al. (2013) found no association in a study of 1612 long-lived individuals (> 95 years old) and 1104 controls (60-75 years old) in a German population. Similarly, we demonstrated that SOD2 is not associated with human longevity in our population.

APOE, located on chromosome 19q13.2, has three different isoforms: ∊2 (cys112, cys158), ∊3 (cys112, arg158), and ∊4 (arg112, arg158), designated by two SNPs, rs429358 (T>C) and rs7412 (C>T). Because of its involvement in cholesterol transport processes, this protein can influence the route of lipids and can lead to oxidative stress, neuronal damage, and inflammation (Huebbe et al., 2011). No association was found between APOE and hypertension in a population of 1406 elderly individuals from Bambuí, Brazil (Fuzikawa et al., 2008). However, the ∊4 allele proved to be a risk factor for premature death in a GWAS study of a Canadian population of healthy oldest-old individuals (Tindale et al., 2014). We did not see a link between APOE and longevity in our population.

SIRT1 is a candidate gene for longevity and promoting health, located on chromosome 10q21.3. The SIRT1 protein resides in a nuclear compartment and is a member of a class I family of seven proteins. The activity of this protein depends on the NAD⁺/NADH ratio, a key indicator for oxygen consumption, suggesting that this protein has a physiological role in regulating metabolic homeostasis (Giblin et al., 2014). Because of SIRT1’s potential role as a mediator of lifespan, SIRT1 polymorphic variants, such as the rs2273773 T>C SNP, have been previously studied (Flachsbart et al., 2006). However, only a small number of SIRT1 SNP studies are related to lifespan in humans. During the last years, these polymorphic variants have been investigated in a context of metabolism or calorie restriction, and have been associated with aging disease-related phenotypes (Nogueiras et al., 2012). This association is also supported by a study that showed that SIRT1 genetic variation affects lipid profiles in a sample of 382 Ashkenazi Jews (Han et al., 2015). Flachsbart et al. (2006) found no association for this SNP in a sample of 1245 long-lived German individuals. Comparably, our findings demonstrated no association between SIRT1 variants and longevity in older individuals.

The present work shows a lack of association between FOXO3 (rs2802292), SOD2 (rs4880), SIRT1 (rs2273773), and APOE (rs429358 and rs7412) with longevity. A possible reason for this result may be the small size of our sample. Longevity association studies frequently use large samples of around 1000 individuals for instance (Di Bona et al., 2014; Broer et al., 2015). However, this is the first longevity study in the state of Espírito Santo, Brazil, and we aim to expand the sample population. Another potential reason may be the different age ranges of the individuals in LLI and control groups. Some studies that have found an association with longevity used different age ranges for LLI and controls (Kilic et al., 2015). Additionally, ethnicity may mask certain genetic marks for longevity, considering Brazilian populations are a mixture of Iberian Caucasians, West Africans, and Native Americans (Pena et al., 2011). Each population has its own ethnic features, and allele and genotype frequencies can vary between different regions.

No relationship was observed between healthy oldest-old individuals and FOXO3, SOD2, APOE, and SIRT1 genotype frequencies. This result can be explained in the context of the data from the Global Burden of Disease Study 2013 (Murray et al., 2015), which showed that the healthy life expectancy of Brazilians, considering disability-adjusted life-years (DALYs) and healthy life expectancy (HALE), is 65 years. Among the LLI of our sample, 61.9% (135) had chronic-degenerative diseases and functional disabilities. Taking into consideration that all individuals in our study were at least 85 years old, our results corroborate with this information, as they were 20 years old or more beyond the healthy life expectative and thus, at risk for morbidities and disability.

In conclusion, although longevity is the result of multiple and complex features, our work suggests that environmental factors and FOXO3 could have an intricate effect on human longevity. Our research contributes to the characterization of the complex mechanisms of aging and lifespan. It may also support the development of better treatments and offer the opportunity for diagnosis and prevention of age-related diseases, thus, postponing aging and/or prolonging healthy lifespan, and establishing more effective public health strategies. Other approaches, such as epigenetic control and gene regulation and expression, also warrant investigation because they can help to understand the mechanisms that regulate lifespan (Kilic et al., 2015; Benayoun et al., 2015). Overall, we believe that our study help to pave the way to a promising future of genomic geriatrics and personalized medicine.

Acknowledgments

We thank the elderly and their families, nurses, and students of Medicine, Nutrition and Biological Science for their participation in this study. This work was supported by the Fundação de Amparo à Pesquisa do Espírito Santo/ Conselho Nacional de Desenvolvimento Científico e Tecnológico/ Ministério da Saúde - Departamento de Ciência e Tecnologia/Secretaria de Estado da Saúde (65849124); and Ministério da Ciência e Tecnologia/ Conselho Nacional de Desenvolvimento Científico e Tecnológico/ Ministério da Educação/ Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (552672/211-4).

References

• Anselmi CV, Malovini A, Roncarati R, Novelli V, Villa F, Condorelli G, Bellazzi R and Puca AA (2009) Association of the FOXO3A locus with extreme longevity in a so uthern Italian centenarian study. Rejuvenation Res 12:95–104.
• Antunes MV, Lazzaretti C, Gamaro GD and Linden R (2008) Estudo pré-analítico e de validação para determinação de malondialdeído em plasma humano por cromatografia líquida de alta eficiência, após derivatização com 2,4-dinitrofenilhidrazina. Braz J Pharm Sci 44:279–287.
• Benayoun BA, Pollina EA and Brunet A (2015) Epigenetic regulation of ageing: linking environmental inputs to genomic stability. Nat Rev Mol Cell Biol 16:593–610.
• Britton A, Shipley M, Singh-Manoux A and Marmot MG (2008) Successful aging: The contribution of early-life and midlife risk factors. J Am Geriatr Soc 56:1098–1105.
• Broer L, Buchman AS, Deelen J, Evans DS, Faul JD, Lunetta KL, Sebastiani P, Smith JA, Smith AV, Tanaka T, et al. (2015) GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. J Gerontol A Biol Sci Med Sci 70:110–118.
• Brooks-Wilson AR (2013) Genetics of healthy aging and longevity. Hum Genet 132:1323–1338.
• Carrano AV and Natarajan AT (1988) International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques. Mutat Res 204:379–406.
• Christensen K, Johnson TE and Vaupel JW (2006) The quest for genetic determinants of human longevity: Challenges and insights. Nat Rev Genet 7:436–448.
• da Cruz IBM (2015) Genetics of aging and its impact on human longevity: Theories and evidences that helps to prevent age-associated diseases. PAJAR - Pan Am J Aging Res 2:3–14.
• Di Bona D, Accardi G, Virruso C, Candore G and Caruso C (2014) Association between genetic variations in the insulin/insulin-like growth factor (Igf-1) signaling pathway and longevity: a systematic review and meta-analysis. Curr Vasc Pharmacol 12:674-681.
• Dutta A, Henley W, Lang I, Llewellyn D, Guralnik J, Wallace RB and Melzer D (2011) Predictors of extraordinary survival in the Iowa established populations for epidemiologic study of the elderly: Cohort follow-up to “extinction”. J Am Geriatr Soc 59:963–971.
• Flachsbart F, Croucher PJP, Nikolaus S, Hampe J, Cordes C, Schreiber S and Nebel A (2006) Sirtuin 1 (SIRT1) sequence variation is not associated with exceptional human longevity. Exp Gerontol 41:98–102.
• Flachsbart F, Caliebe A, Kleindorp R, Kleindorp R, Blanche H, von Eller-Eberstein H, Nikolaus S, Schreiber S and Nebel A (2009) Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Natl Acad Sci U S A 106:2700-2705.
• Flores G, Cruz AAM, Taufer M, Siviero J, Nascimento NM, and Moriguchi EH (2013) Indicadores de saúde dos idosos participantes do Projeto Gravataí. Rev Med PUC/RS 13:393–399.
• Fragoso MCBV, Alencar GA, Lerario AM, Bourdeau I, Almeida MQ, Mendonca BB and Lacroix A (2015) Genetics of primary macronodular adrenal hyperplasia. J Endocrinol 224:R31-R43.
• Franzke B, Neubauer O and Wagner K-H (2015) Super DNAging - new insights into DNA integrity, genome stability and telomeres in the oldest old. Mutat Res Rev Mutat Res 766:48–57.
• Fuzikawa AK, Peixoto SV, Taufer M, Moriguchi EH and Lima-Costa MF (2008) Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS). Braz J Med Biol Res 41:89–94.
• Gentschew L, Flachsbart F, Kleindorp R, Badarinarayan N, Schreiber S and Nebel A (2013) Polymorphisms in the superoxidase dismutase genes reveal no association with human longevity in Germans: A case-control association study. Biogerontology 14:719–727.
• Giblin W, Skinner ME and Lombard DB (2014) Sirtuins: Guardians of mammalian healthspan. Trends Genet 30:271–286.
• Han J, Atzmon G, Barzilai N and Suh Y (2015) Genetic variation in Sirtuin 1 (SIRT1) is associated with lipid profiles but not with longevity in Ashkenazi Jews. Transl Res 165: 480–481.
• Hodge AM, O’Dea K, English DR, Giles GG and Flicker L (2014) Dietary patterns as predictors of successful ageing. J Nutr Health Aging 18:221–227.
• Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang L-L et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191–196.
• Huebbe P, Nebel A, Siegert S, Moehring J, Boesch-Saadatmandi C, Most E, Pallauf J, Egert S, Müller MJ, Schreiber S et al. (2011) APOE ∊4 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J 25: 3262–3270.
• Instituto Brasileiro de Geografia e Estatística (2013) Tábua completa de mortalidade para o Brasil. IBGE, Rio de Janeiro, RJ 1-26 p.
• Instituto Brasileiro de Geografia e Estatística (2010) Síntese de Indicadores Sociais. IBGE, Rio de Janeiro, RJ, 1-317 p.
• Kilic U, Gok O, Erenberk U, Dundaroz MR, Torun E, Kucukardali Y, Elibol-Can B, Uysal O and Dundar T (2015) A remarkable age-related increase in SIRT1 protein expression against oxidative stress in elderly: SIRT1 gene variants and longevity in human. PLoS One 10:e0117954.
• Martins R, Lithgow GJ and Link W (2016) Long live FOXO: Unraveling the role of FOXO proteins in aging and longevity. Aging Cell 15:196–207.
• Miller SA, Dykes DD and Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
• Murray CJL, Barber RM, Foreman KJ, Ozgoren AA, Abd-Allah F, Abera SF, Aboyans V, Abraham JP, Abubakar I, Abu-Raddad LJ et al. (2015) Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386:2145–2191.
• Nair AK, Sugunan D, Kumar H and Anilkumar G (2012) Association analysis of common variants in FOXO3 with type 2 diabetes in a South Indian Dravidian population. Gene 491:182–186.
• Nogueiras R, Habegger KM, Chaudhary N, Finan B, Banks AS, Dietrich MO, Horvath TL, Sinclair DA, Pfluger PT and Tschöp MH (2012) Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev 92:1479–1514.
• De Oliveira JEP and Vencio S (2015) Diretrizes da Sociedade Brasileira de Diabetes: 2014-2015. GEN, São Paulo, 374 p.
• Organizacão Pan-Americana da Saúde (2003) Doenças crônico-degenerativas e obesidade: Estratégia mundial sobre alimentação saudável, atividade física e saúde. OPAS, Brasília, DF, 60 p
• Pena SDJ, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, Kehdy FSG, Kohlrausch F, Magno LAV, Montenegro RC, Moraes MO et al. (2011) The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One 6:e17063.
• Perls T, Shea-Drinkwater M, Bowen-Flynn J, Ridge SB, Kang S, Joyce E, Daly M, Brewster SJ, Kunkel L and Puca AA (2000) Exceptional familial clustering for extreme longevity in humans. J Am Geriatr Soc 48: 1483–1485.
• Praticò D (2002) Lipid peroxidation and the aging process. Sci Aging Knowledge Environ 2002:re5.
• Saeed SA, Urfy MZS, Ali TM, Khimani FW and Gilani AH (2005) Antioxidants: Their role in health and disease. Int J Pharmacol 1:226–233.
• Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y and Mizuno Y (1996) Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson’s disease. Biochem Biophys Res Commun 226:561–565.
• Simm A and Klotz L-O (2015) Stress and biological aging: A double-edged sword. Z Gerontol Geriatr 48:505–510.
• Singh NP, McCoy MT, Tice RR and Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191.
• Soerensen M, Christensen K, Stevnsner T and Christiansen L (2009) The Mn-superoxide dismutase single nucleotide polymorphism rs4880 and the glutathione peroxidase 1 single nucleotide polymorphism rs1050450 are associated with aging and longevity in the oldest old. Mech Ageing Dev 130:308–314.
• Soerensen M, Nygaard M, Dato S, Stevnsner T, Bohr VA, Christensen K and Christiansen L (2015) Association study of FOXO3A SNPs and aging phenotypes in Danish oldest-old individuals. Aging Cell 14:60–66.
• Taufer M, Peres A, de Andrade VM, de Oliveira G, Sá G, do Canto MEP, dos Santos AR, Bauer ME and da Cruz IBM (2005) Is the Val16Ala manganese superoxide dismutase polymorphism associated with the aging process? J Gerontol A Biol Sci Med Sci 60:432–438.
• Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC and Sasaki YF (2000) Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–221.
• Tindale LC, Leach S, Ushey K, Daley D and Brooks-Wilson AR (2014) Rare and common variants in the Apolipoprotein E gene in healthy oldest old. Neurobiol Aging 35:727.e1-727.e3.
• Tyrovolas S, Polychronopoulos E, Mariolis A, Piscopo S, Valacchi G, Makri K, Zeimbekis A, Tyrovola D, Bountziouka V, Gotsis E et al. (2016) Is parental longevity associated with the cardiovascular risk and the successful aging of their offspring? Results from the multinational MEDIS study. Angiology 68:124–131.
• Tzivion G, Dobson M and Ramakrishnan G (2011) FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta 1813:1938–1945.
• Ware JE and Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483.
• Willcox BJ, Donlon TA, He Q, Chen R, Grove JS, Yano K, Masaki KH, Willcox DC, Rodriguez B and Curb JD (2008) FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A 105:13987–13992.
• World Health Organization (2000) Defining the problem of overweight and obesity. In: World Health Organization. Obesity: preventing and managing the global epidemic: Report of a WHO Consultation. WHO Report Ser 894e, Geneva, 252 p.
• Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, Fonseca FA, dos Santos JE, Santos RD, Bertolami MC et al. (2013) V Diretriz brasileira de dislipidemia e prevenção da aterosclerose. Arq Bras Cardiol 101:1-20.
• Zhong L, Xie Y-Z, Cao T-T, Wang Z, Wang T, Li X, Shen R-C, Xu H, Bu G and Chen X-F (2016) A rapid and cost-effective method for genotyping apolipoprotein E gene polymorphism. Mol Neurodegener 11:2–8.

Internet Resources

• HGVS - Human Genome Variation Society, http://www.hgvs.org/central-mutation-snp-databases (accessed in March, 2016).
  » http://www.hgvs.org/central-mutation-snp-databases

• Associate Editor: Maria Rita Passos-Bueno

Publication Dates

• Publication in this collection
  11 June 2018
• Date of issue
  Apr./June 2018

History

• Received
  02 June 2017
• Accepted
  23 Nov 2017